-
1
-
-
0037030658
-
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
-
Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-80.
-
(2002)
N Engl J Med
, vol.346
, pp. 1773-1780
-
-
Morice, M.C.1
Serruys, P.W.2
Sousa, J.E.3
-
2
-
-
10744222911
-
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis
-
Holmes DR Jr, Leon MB, Moses JW, et al. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation 2004;109: 634-40.
-
(2004)
Circulation
, vol.109
, pp. 634-640
-
-
Holmes Jr., D.R.1
Leon, M.B.2
Moses, J.W.3
-
3
-
-
11144357913
-
One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial
-
Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004;109: 1942-7.
-
(2004)
Circulation
, vol.109
, pp. 1942-1947
-
-
Stone, G.W.1
Ellis, S.G.2
Cox, D.A.3
-
4
-
-
20244382131
-
Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial
-
Hermiller JB, Raizner A, Cannon L, et al. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 2005;45:1172-9.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1172-1179
-
-
Hermiller, J.B.1
Raizner, A.2
Cannon, L.3
-
5
-
-
29344467706
-
ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)
-
Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006;47: 216-35.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 216-235
-
-
Smith Jr., S.C.1
Feldman, T.E.2
Hirshfeld Jr., J.W.3
-
6
-
-
33847736642
-
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
-
Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
-
(2007)
N Engl J Med
, vol.356
, pp. 998-1008
-
-
Stone, G.W.1
Moses, J.W.2
Ellis, S.G.3
-
7
-
-
34347360825
-
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry
-
Marzocchi A, Saia F, Piovaccari G, et al. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 2007;115:3181-8.
-
(2007)
Circulation
, vol.115
, pp. 3181-3188
-
-
Marzocchi, A.1
Saia, F.2
Piovaccari, G.3
-
8
-
-
33751019660
-
Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry
-
Williams DO, Abbott JD, Kip KE. Outcomes of 6906 patients undergoing percutaneous coronary intervention in the era of drug-eluting stents: report of the DEScover Registry. Circulation 2006;114:2154-62.
-
(2006)
Circulation
, vol.114
, pp. 2154-2162
-
-
Williams, D.O.1
Abbott, J.D.2
Kip, K.E.3
-
9
-
-
20044388113
-
Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies
-
Moreno R, Fernandez C, Hernandez R, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-9.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 954-959
-
-
Moreno, R.1
Fernandez, C.2
Hernandez, R.3
-
10
-
-
33847705701
-
Stent thrombosis in randomized clinical trials of drug-eluting stents
-
Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9.
-
(2007)
N Engl J Med
, vol.356
, pp. 1020-1029
-
-
Mauri, L.1
Hsieh, W.H.2
Massaro, J.M.3
-
11
-
-
15844430483
-
One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial
-
van Hout BA, Serruys PW, Lemos PA, et al. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart 2005;91:507-12.
-
(2005)
Heart
, vol.91
, pp. 507-512
-
-
van Hout, B.A.1
Serruys, P.W.2
Lemos, P.A.3
-
12
-
-
3543064732
-
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial
-
Cohen DJ, Bakhai A, Shi C, et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 2004; 110:508-14.
-
(2004)
Circulation
, vol.110
, pp. 508-514
-
-
Cohen, D.J.1
Bakhai, A.2
Shi, C.3
-
13
-
-
33745708066
-
Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial
-
Bakhai A, Stone GW, Mahoney E, et al. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial. J Am Coll Cardiol 2006;48:253-61.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 253-261
-
-
Bakhai, A.1
Stone, G.W.2
Mahoney, E.3
-
14
-
-
33845665465
-
Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry
-
Ong AT, Daemen J, van Hout BA, et al. Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry. Eur Heart J 2006;27:2996-3003.
-
(2006)
Eur Heart J
, vol.27
, pp. 2996-3003
-
-
Ong, A.T.1
Daemen, J.2
van Hout, B.A.3
-
15
-
-
24644523719
-
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET)
-
Kaiser C, Brunner-La Rocca HP, Buser PT, et al. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitats Trial (BASKET). Lancet 2005;366:921-9.
-
(2005)
Lancet
, vol.366
, pp. 921-929
-
-
Kaiser, C.1
Brunner-La Rocca, H.P.2
Buser, P.T.3
-
16
-
-
2342623439
-
Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues
-
Hodgson JM, Bottner RK, Klein LW, et al. Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues. Catheter Cardiovasc Interv 2004;62:1-17.
-
(2004)
Catheter Cardiovasc Interv
, vol.62
, pp. 1-17
-
-
Hodgson, J.M.1
Bottner, R.K.2
Klein, L.W.3
|